Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 111 through 120 of 159 results (Download Results)

Show results per page

Immune response after COVID‑19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

Chandran, Vinod | University Health Network | Operating Grant | $499,800

CIHR Ontario 2021

COVID-19 Variant Supplement – Molecular and cellular therapies against COVID‑19 using angiotensin-converting enzyme 2 (ACE2)

Zhang, Haibo | Keenan Research Centre | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Network – The COVID‑19 Hospital Analytics Laboratory: Improving the Clinical, Organizational, and System Response to COVID-19

Verma, Amol | Unity Health Toronto | Operating Grant | $100,000

CIHR Ontario 2021

Vaccine effectiveness against SARS-CoV-2 variants of concern in long-term care populations: a multi-province study

Hsu, Amy T | Bruyère Research Institute | Operating Grant | $500,000

CIHR Ontario 2021

COVID-19 Variant Supplement – A low-cost, portable, and decentralized microfluidic device for detecting SARS-CoV-2 neutralizing antibodies

Little, Dustin J | Ryerson University | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Targeting genetic and chemical vulnerabilities of novel coronavirus SARS-CoV-2

Wright, Gerard D | McMaster University | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Shutting down emerging Coronaviruses in humans now and in the future

Barr, Stephen D | Western University | Operating Grant | $50,000

CIHR Ontario 2021

Predictors and burden of post-acute COVID‑19 syndrome (long-COVID) with a focus on equity

Sander, Beate H | Toronto General Research Institute | Operating Grant | $499,645

CIHR Ontario 2021

COVID-19 Variant Network – Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2

Watts, Tania H | University of Toronto | Operating Grant | $100,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial

Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $50,000

CIHR Ontario 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Immune response after COVID‑19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

COVID-19 Variant Supplement – Molecular and cellular therapies against COVID‑19 using angiotensin-converting enzyme 2 (ACE2)

COVID-19 Variant Network – The COVID‑19 Hospital Analytics Laboratory: Improving the Clinical, Organizational, and System Response to COVID-19

Vaccine effectiveness against SARS-CoV-2 variants of concern in long-term care populations: a multi-province study

COVID-19 Variant Supplement – A low-cost, portable, and decentralized microfluidic device for detecting SARS-CoV-2 neutralizing antibodies

COVID-19 Variant Supplement – Targeting genetic and chemical vulnerabilities of novel coronavirus SARS-CoV-2

COVID-19 Variant Supplement – Shutting down emerging Coronaviruses in humans now and in the future

Predictors and burden of post-acute COVID‑19 syndrome (long-COVID) with a focus on equity

COVID-19 Variant Network – Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial